& Pearson, W
Acknowledgements We thank Celina Nhan, Jack Chen, Nina Juntereal, Anh Cao, Claudia Liberini, and Samantha Fortin for valuable technical assistance
While these findings should be interpreted in light of the observational nature of the analysis and the limited sample size, they raise questions about the presumed (pulmonary) safety of paracetamol in extremely preterm infants
BioMed research international, 2017, 6274854
published the results of a phase 3 clinical trial of tirzepatide, a dual GIP and GLP-1 receptor agonist, in patients with T2DM, showing significant results in glycemic control and weight loss (Rosenstock et al., 2021)